University Hospitals of Leicester NHS Trust
Leicester, Leicestershire, LE1 5WW, United Kingdom
NCT Number: NCT01870817
After surgery for oesophageal (gullet) or gastric (stomach) cancer, patients are routinely fed by means of a small feeding tube into the intestine (jejunostomy, JEJ) while they are in hospital. Current practice is to stop feeding once the patient leaves hospital, although the tube is left in place for the first 6 weeks. Most patients lose weight after surgery and have to learn to adjust to new eating habits and behaviours. A few patients have the JEJ feed restarted because of nutritional problems and this requires a further inpatient stay.
It is unknown whether every patient would benefit from this type of feeding at home. Previous studies have only assessed the value of JEJ feeding while patients are still in hospital. There is little known about the benefit of continuing JEJ feeding after discharge from hospital, although home feeding is not uncommon in other patient groups (eg. after a stroke).
The proposed study will provide initial information on patients' well being by measuring quality of life and factors such as change in body weight and dietary intake following a period of home JEJ feeding after surgery. Subjects recruited into the study will be placed, randomly, into a control group who receive current nutritional care (based on dietary advice and oral nutritional supplement drinks) or an intervention group who will receive home JEJ feeding for 6 weeks after hospital discharge, in addition to current treatment.
If subjects in the control group are experiencing problems eating at home, home feeding through the JEJ tube will be started as needed.
The study will also examine how surgery and JEJ feeding at home impact on the patient and carer(s) by means of questionnaires and interviews conducted in the patients' home.
Information obtained will assist in the design of a multicentre study. This intervention is considered important because it has the potential to benefit thousands of patients each year at a modest cost.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Leicester, Leicestershire, LE1 5WW, United Kingdom
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 7 months
This pilot study will inform the design and planning of a larger multi-centre study
Time frame: Recruitment, 3 wks, 6 wks, 3 months, 6 months after surgery
Variability in disease specific and generic quality of life measures will be assessed
Time frame: Recruitment, 3 wks, 6 wks, 3 months, 6 months after surgery
Absolute body weight
Time frame: 7 months
Estimates of healthcare costs for the duration of the study will be calculated
Time frame: 7 months
Readmission rate to hospital during the study period
Time frame: 8 weeks
Interviews will be conducted with up to 10 participants and their carers & thematic qualitative analysis of interviews performed
Time frame: Recruitment, 3 wks, 6 wks, 3 months, 6 months after surgery
Self-completed 3 day food diaries will be assessed
Time frame: Recruitment, 3 wks, 6 wks, 3 months, 6 months after surgery
Body mass index
Time frame: Recruitment, 3 wks, 6 wks, 3 months, 6 months after surgery
Mid arm circumference
Time frame: Recruitment, 3 wks, 6 wks, 3 months, 6 months after surgery
Triceps fold thickness
Time frame: Recruitment, 3 wks, 6 wks, 3 months, 6 months after surgery
Grip strength
University Hospitals, Leicester
Other
A Pilot Study Investigating the Effect of Post-operative Home Jejunostomy Feeding on Quality of Life and Nutritional Parameters in Patients With Oesophago-gastric Cancer
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01719926
Adnexal Diseases, Colonic Diseases
Amsterdam, Netherlands
View Trial DetailsNCT00213486
Digestive System Diseases, Digestive System Neoplasms
Rouen, France
View Trial DetailsNCT02359968
Digestive System Diseases, Digestive System Neoplasms
Angers, France
View Trial DetailsNCT06027515
Digestive System Diseases, Digestive System Neoplasms
Boston, Massachusetts, United States
View Trial Details